Literature DB >> 14985099

A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.

Yasufumi Kikuchi1, Shinsuke Uno, Yasushi Yoshimura, Koji Otabe, Shin-ichiro Iida, Masayoshi Oheda, Naoshi Fukushima, Masayuki Tsuchiya.   

Abstract

We constructed a single-chain antibody fragment (scFv) of murine monoclonal antibody, MABL, which specifically bound to human CD47 (hCD47) and induced apoptosis of the leukemic cells. The scFv of MABL antibody with a 15-residue linker (MABL scFv-15) formed both dimer (Mr 50 kDa) and monomer (Mr 25 kDa). Both MABL scFv-15 dimer and monomer had binding activity for hCD47. MABL scFv-15 dimer strongly induced apoptosis of hCD47-introduced mouse leukemic cells in vitro and exhibited anti-tumor effect in a myeloma transplanted mice model. However, MABL scFv-15 monomer scarcely exhibited these activities. These results strongly demonstrate that the ligation of CD47 antigen by two antigen-binding sites of MABL dimer is needed for inducing apoptosis. The parent MABL antibody caused hemagglutination due to the CD47 expressed on erythrocytes. Interestingly, MABL scFv-15 dimer did not cause hemagglutination. This apoptosis-inducing dimer appears to be a lead candidate for novel leukemic therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985099     DOI: 10.1016/j.bbrc.2004.01.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

Review 2.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 3.  Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth review.

Authors:  Atlantis Russ; Anh B Hua; William R Montfort; Bushra Rahman; Irbaz Bin Riaz; Muhammad Umar Khalid; Jennifer S Carew; Steffan T Nawrocki; Daniel Persky; Faiz Anwer
Journal:  Blood Rev       Date:  2018-04-14       Impact factor: 8.250

4.  Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.

Authors:  Mark P Chao; Ash A Alizadeh; Chad Tang; June H Myklebust; Bindu Varghese; Saar Gill; Max Jan; Adriel C Cha; Charles K Chan; Brent T Tan; Christopher Y Park; Feifei Zhao; Holbrook E Kohrt; Raquel Malumbres; Javier Briones; Randy D Gascoyne; Izidore S Lossos; Ronald Levy; Irving L Weissman; Ravindra Majeti
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

Review 5.  Targeting CD47 as a Novel Immunotherapy for Breast Cancer.

Authors:  Can Chen; Runlu Wang; Xi Chen; Yulong Hou; Jingting Jiang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

6.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

7.  Preclinical and Clinical Development of Therapeutic Antibodies Targeting Functions of CD47 in the Tumor Microenvironment.

Authors:  Sukhbir Kaur; Kyle V Cicalese; Rajdeep Bannerjee; David D Roberts
Journal:  Antib Ther       Date:  2020-08-08

8.  Susceptibility of rhabdomyosarcoma cells to macrophage-mediated cytotoxicity.

Authors:  Delia Herrmann; Guido Seitz; Jörg Fuchs; Sorin Armeanu-Ebinger
Journal:  Oncoimmunology       Date:  2012-05-01       Impact factor: 8.110

9.  Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.

Authors:  Rama Krishna Narla; Hardik Modi; Daniel Bauer; Mahan Abbasian; Jim Leisten; Joseph R Piccotti; Stephan Kopytek; Brendan P Eckelman; Quinn Deveraux; John Timmer; Dan Zhu; Lilly Wong; Laure Escoubet; Heather K Raymon; Kandasamy Hariharan
Journal:  Cancer Immunol Immunother       Date:  2021-07-10       Impact factor: 6.968

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.